Child Neurology Society

Intranasal Diazepam Safe, Tolerable in Pediatric Epilepsy

October 29, 2019

Analysis of long-term safety of intranasal diazepam shows favorable results in children and adolescents with cluster or acute, repetitive seizures.

Deflazacort Superior to Prednisone for Treatment of Duchenne Muscular Dystrophy

October 28, 2019

Study results show that deflazacort tops prednisone across multiple checkpoints in patients with Duchenne muscular dystrophy.

New Assessment May Better Screen Adolescents With Epilepsy for Adult Transition

October 25, 2019

Epilepsy-specific TRAQ questionnaire shows high validity in pediatric epilepsy patients transitioning to adult epilepsy care.

CBD Shows Long-Term Safety as Add-On Therapy in Lennox-Gastaut Syndrome

October 25, 2019

Data presented at the Child Neurology Society Annual Meeting suggest that the safety and efficacy of cannabidiol (Epidiolex; GW Pharmaceuticals) is maintained through 72 weeks of treatment for patients with LGS.

Botox Improves Gait, Pain in Pediatric Patients With Lower Limb Spasticity

October 24, 2019

The drug recently gained FDA approval for treatment of lower limb spasticity in pediatric patients without cerebral palsy, in which it is associated with improved functional outcomes.

Fenfluramine Reduces Frequency of TC Seizures in Dravet Syndrome

October 23, 2019

A pooled analysis of 2 phase 3 trials of fenfluramine demonstrate the clinical potential of the drug for patients with Dravet syndrome.